Imaging in clinical decision-making for portal vein thrombosis

Nature Reviews Gastroenterology and Hepatology

Volumn 11, Issue 5, 2014, Pages 308-316

  Berzigotti, Annalisa ^a   García Criado, Ángeles ^a   Darnell, Anna ^a   García Pagán, Juan Carlos ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BENIGN TUMOR; BILIARY TRACT DISEASE; CLINICAL DECISION MAKING; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; ECHOGRAPHY; ELASTOGRAPHY; FOLLOW UP; HUMAN; IMAGING; LIVER CANCER; LIVER CIRRHOSIS; LIVER VEIN THROMBOSIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREATITIS; PORTAL VEIN THROMBOSIS; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SPLENOMEGALY; DOPPLER FLOWMETRY; PORTAL VEIN; PROCEDURES; VENOUS THROMBOSIS;

FIBRINOLYTIC AGENT;

DIAGNOSTIC IMAGING; FIBRINOLYTIC AGENTS; HUMANS; MAGNETIC RESONANCE IMAGING; PORTAL VEIN; TOMOGRAPHY, X-RAY COMPUTED; ULTRASONOGRAPHY, DOPPLER; VENOUS THROMBOSIS;

EID: 84900384901     PISSN: 17595045     EISSN: 17595053     Source Type: Journal    
DOI: 10.1038/nrgastro.2013.258     Document Type: Review

References (69)

1. Yerdel, M. A. et al. Portal vein thrombosis in adults undergoing liver transplantation: risk factors, screening, management, and outcome. Transplantation 69, 1873-1881 (2000).
2. Rajani, R. et al. The epidemiology and clinical features of portal vein thrombosis: a multicentre study. Aliment. Pharmacol. Ther. 32, 1154-1162 (2010).
3. Garcia-Pagan, J. C., Hernandez-Guerra, M. & Bosch, J. Extrahepatic portal vein thrombosis. Semin. Liver Dis. 28, 282-292 (2008).
4. Plessier, A. et al. Acute portal vein thrombosis unrelated to cirrhosis: a prospective multicenter follow-up study. Hepatology 51, 210-218 (2010).
5. Valla, D. et al. Etiology of portal vein thrombosis in adults. A prospective evaluation of primary myeloproliferative disorders. Gastroenterology 94, 1063-1069 (1988).
6. Denninger, M. H. et al. Cause of portal or hepatic venous thrombosis in adults: the role of multiple concurrent factors. Hepatology 31, 587-591 (2000).
7. Primignani, M. et al. Risk factors for thrombophilia in extrahepatic portal vein obstruction. Hepatology 41, 603-608 (2007).
8. Turnes, J. et al. Portal hypertension-related complications after acute portal vein thrombosis: impact of early anticoagulation. Clin. Gastroenterol. Hepatol 6, 1412-1417 (2008).
9. Nonami, T., Yokoyama, I., Iwatsuki, S. & Starzl, T. E. The incidence of portal vein thrombosis at liver transplantation. Hepatology 16, 1195-1198 (1992).
10. Tripodi, A., Anstee, Q. M., Sogaard, K. K., Primignani, M. & Valla, D. C. Hypercoagulability in cirrhosis: causes and consequences. J. Thromb. Haemost. 9, 1713-1723 (2011).
11. Tripodi, A. & Mannucci, P. M. The coagulopathy of chronic liver disease. N. Engl. J. Med. 365, 147-156 (2011).
12. Amitrano, L. et al. Risk factors and clinical presentation of portal vein thrombosis in patients with liver cirrhosis. J. Hepatol. 40, 736-741 (2004).
13. Francoz, C. et al. Splanchnic vein thrombosis in candidates for liver transplantation: usefulness of screening and anticoagulation. Gut 54, 691-697 (2005).
14. Englesbe, M. J. et al. Portal vein thrombosis and survival in patients with cirrhosis. Liver Transpl. 16, 83-90 (2010).
15. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J. Hepatol. 56, 908-943 (2012).
16. Delgado, M. G. et al. Efficacy and safety of anticoagulation on patients with cirrhosis and portal vein thrombosis. Clin. Gastroenterol. Hepatol. 10, 776-783 (2012).
17. Tessler, F. N. et al. Diagnosis of portal vein thrombosis: value of color Doppler imaging. AJR Am. J. Roentgenol. 157, 293-296 (1991).
18. Bach, A. M. et al. Portal vein evaluation with US: comparison to angiography combined with CT arterial portography. Radiology 201, 149-154 (1996).
19. Chawla, Y. & Kumar, S. Portal venous flow in Budd-Chiari syndrome [letter]. Indian J. Gastroenterol. 17, 37 (1998).
20. Gertsch, P., Matthews, J., Lerut, J., Luder, P. & Blumgart, L. H. Acute thrombosis of the splanchnic veins. Arch. Surg. 128, 341-345 (1993).
21. Berzigotti, A., Zoli, M., Bru, C. & Gilabert, R. in Portal Hypertension V: Proceedings of the Fifth Baveno International Consensus Workshop (ed. de Franchis, R. ) 28-36 (Wiley Blackwell, 2010).
22. Berzigotti, A. & Piscaglia, F. Ultrasound in portal hypertensionpart 2and EFSUMB recommendations for the performance and reporting of ultrasound examinations in portal hypertension. Ultraschall. Med. 33, 8-32 (2012).
23. Grant, E. G., Tessler, F. N. & Perrella, R. R. Clinical Doppler imaging. AJR Am. J. Roentgenol. 152, 707-717 (1989).
24. Claudon, M. et al. Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) in the liverupdate 2012: a WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS. Ultraschall. Med. 34, 11-29 (2013).
25. Rossi, S. et al. Contrast-enhanced versus conventional and color Doppler sonography for the detection of thrombosis of the portal and hepatic venous systems. AJR Am. J. Roentgenol. 186, 763-773 (2006).
26. Sabba, C. et al. Interobserver and interequipment variability of echo-Doppler examination of the portal vein: effect of a cooperative training program. Hepatology 21, 428-433 (1995).
27. Kuszyk, B. S. et al. Portal venous system thrombosis: helical CT angiography before transjugular intrahepatic portosystemic shunt creation. Radiology 206, 179-186 (1998).
28. Mori, H. et al. High-attenuation recent thrombus of the portal vein: CT demonstration and clinical significance. Radiology 163, 353-356 (1987).
29. DeLeve, L. D., Valla, D. C. & Garcia-Tsao, G. Vascular disorders of the liver. Hepatology 49, 1729-1764 (2009).
30. Sodickson, A. et al. Recurrent CT, cumulative radiation exposure, and associated radiation-induced cancer risks from CT of adults. Radiology 251, 175-184 (2009).
31. American College of Radiology. Manual on Contrast Media version 8, 33-42 (2012).
32. Shimada, K. et al. Non-contrast-enhanced MR portography with time-spatial labeling inversion pulses: comparison of imaging with three-dimensional half-fourier fast spin-echo and true steady-state free-precession sequences. J. Magn. Reson. Imaging 29, 1140-1146 (2009).
33. Berzigotti, A. et al. Ultrasonographic evaluation of liver surface and transient elastography in clinically doubtful cirrhosis. J. Hepatol. 52, 846-853 (2010).
34. Colli, A. et al. Severe liver fibrosis or cirrhosis: accuracy of US for detectionanalysis of 300 cases. Radiology 227, 89-94 (2003).
35. Vilgrain, V. et al. Atrophy-hypertrophy complex in patients with cavernous transformation of the portal vein: CT evaluation. Radiology 241, 149-155 (2006).
36. Hillaire, S. et al. Idiopathic non-cirrhotic intrahepatic portal hypertension in the West: a re-evaluation in 28 patients. Gut 51, 275-280 (2002).
37. Seijo, S. et al. Role of hepatic vein catheterisation and transient elastography in the diagnosis of idiopathic portal hypertension. Dig. Liver Dis. 44, 855-860 (2012).
38. Sharma, P., Mishra, S. R., Kumar, M., Sharma, B. C. & Sarin, S. K. Liver and spleen stiffness in patients with extrahepatic portal vein obstruction. Radiology 263, 893-899 (2012).
39. Friedrich-Rust, M. et al. Liver fibrosis in viral hepatitis: noninvasive assessment with acoustic radiation force impulse imaging versus transient elastography. Radiology 252, 595-604 (2009).
40. Ferraioli, G. et al. Accuracy of real-time shear wave elastography for assessing liver fibrosis in chronic hepatitis C: a pilot study. Hepatology 56, 2125-2133 (2012).
41. Harris, S., Nadkarni, N. A., Naina, H. V. & Vege, S. S. Splanchnic vein thrombosis in acute pancreatitis: a single-center experience. Pancreas 42, 1251-1254 (2013).
42. Calvet, X. et al. Natural history of hepatocellular carcinoma in Spain. Five year's experience in 249 cases. J. Hepatol. 10, 311-317 (1990).
43. Stuart, K. E., Anand, A. J. & Jenkins, R. L. Hepatocellular carcinoma in the United States. Prognostic features, treatment outcome, and survival. Cancer 77, 2217-2222 (1996).
44. Rossi, S. et al. Contrast-enhanced ultrasonography and spiral computed tomography in the detection and characterization of portal vein thrombosis complicating hepatocellular carcinoma. Eur. Radiol. 18, 1749-1756 (2008).
45. Raab, B. W. The thread and streak sign. Radiology 236, 284-285 (2005).
46. Catalano, O. A., Choy, G., Zhu, A., Hahn, P. F. & Sahani, D. V. Differentiation of malignant thrombus from bland thrombus of the portal vein in patients with hepatocellular carcinoma: application of diffusion-weighted MR imaging. Radiology 254, 154-162 (2010).
47. Qian, L. J. et al. Differentiation of neoplastic from bland macroscopic portal vein thrombi using dual-energy spectral CT imaging: a pilot study. Eur. Radiol. 22, 2178-2185 (2012).
48. Piscaglia, F. et al. Criteria for diagnosing benign portal vein thrombosis in the assessment of patients with cirrhosis and hepatocellular carcinoma for liver transplantation. Liver Transpl. 16, 658-667 (2010).
49. de Ville de Goyet, J. et al. Direct bypassing of extrahepatic portal venous obstruction in children: a new technique for combined hepatic portal revascularization and treatment of extrahepatic portal hypertension. J. Pediatr. Surg. 33, 597-601 (1998).
50. Hanbidge, A. E., Lynch, D. & Wilson, S. R. US of the peritoneum. Radiographics 23, 663-684 (2003).
51. de Ville de Goyet, J. et al. Meso-Rex bypass as an alternative technique for portal vein reconstruction at or after liver transplantation in children: review and perspectives. Pediatr. Transplant. 17, 19-26 (2013).
52. Chaves, I. J. et al. Pre- and postoperative imaging and interventions for the meso-Rex bypass in children and young adults. Pediatr. Radiol. 42, 220-232 (2012).
53. Cakmak, O. et al. Role of contrast-enhanced 3D magnetic resonance portography in evaluating portal venous system compared with color Doppler ultrasonography. Abdom. Imaging 33, 65-71 (2008).
54. Seeger, M. et al. Chronic portal vein thrombosis: transcapsular hepatic collateral vessels and communicating ectopic varices. Radiology 257, 568-578 (2010).
55. Miyamoto, A. et al. Living-related liver transplantation with renoportal anastomosis for a patient with large spontaneous splenorenal collateral. Transplantation 75, 1596-1598 (2003).
56. Brancatelli, G., Federle, M. P., Pealer, K. & Geller, D. A. Portal venous thrombosis or sclerosis in liver transplantation candidates: preoperative CT findings and correlation with surgical procedure. Radiology 220, 321-328 (2001).
57. Luca, A. et al. Short- and long-term effects of the transjugular intrahepatic portosystemic shunt on portal vein thrombosis in patients with cirrhosis. Gut 60, 846-852 (2011).
58. Dhiman, R. K., Behera, A., Chawla, Y. K., Dilawari, J. B. & Suri, S. Portal hypertensive biliopathy. Gut 56, 1001-1008 (2007).
59. Condat, B. et al. Portal cavernoma-associated cholangiopathy: a clinical and MR cholangiography coupled with MR portography imaging study. Hepatology 37, 1302-1308 (2003).
60. Llop, E. et al. Portal cholangiopathy: radiological classification and natural history. Gut 60, 853-860 (2011).
61. Galati, G. et al. A mocking finding: portal cavernoma mimicking neoplastic mass. First sign of myeloproliferative disorder in a patient with Janus kinase2 V617F mutation. Eur. J. Gastroenterol. Hepatol. 21, 233-236 (2009).
62. Plessier, A., Rautou, P. E. & Valla, D. C. Management of hepatic vascular diseases. J. Hepatol. 56 (Suppl. 1), S25-S38 (2012).
63. Spaander, M. C. et al. Anticoagulant therapy in patients with non-cirrhotic portal vein thrombosis: effect on new thrombotic events and gastrointestinal bleeding. J. Thromb. Haemost. 11, 452-459 (2013).
64. Francoz, C., Valla, D. & Durand, F. Portal vein thrombosis, cirrhosis, and liver transplantation. J. Hepatol. 57, 203-212 (2012).
65. Luca, A. et al. Natural course of extrahepatic nonmalignant partial portal vein thrombosis in patients with cirrhosis. Radiology 265, 124-132 (2012).
66. Maruyama, H. et al. Prediction of the therapeutic effects of anticoagulation for recent portal vein thrombosis: a novel approach with contrast-enhanced ultrasound. Abdom. Imaging 37, 431-438 (2012).
67. Brenner, D. J. & Hall, E. J. Computed tomographyan increasing source of radiation exposure. N. Engl. J. Med. 357, 2277-2284 (2007).
68. Reiter, T. et al. Minimizing risk of nephrogenic systemic fibrosis in cardiovascular magnetic resonance. J. Cardiovasc. Magn. Reson. 14, 31 (2012).
69. Berzigotti, A., Piscaglia, F. & EFSUMB Education and Professional Standard Committee. Clinical recommendations for the performance and reporting of ultrasound examination for portal hypertension European Federation of Societies for Ultrasound in Medicine and Biology [online], http://www. efsumb-portal. org/ep/article. php?id=108 (2011).